TMO continues to capture investors' attention due to its innovative product launches and trusted partnership status.

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

Investors focused on top-and-bottom-line performance—important as they are—do so at the risk of neglecting another crucial ...

Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

The market expects Thermo Fisher Scientific (TMO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2024 results on Jan. 30, before market open. See the ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $573.06 which represents a slight increase of $13.41 or 2.40% from the prior close of $559.65. The stock opened at $563 ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...

Thermo Fisher Scientific Inc. closed 8.73% below its 52-week high of $627.88, which the company reached on September 10th.

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...